RT Journal Article
SR Electronic
T1 Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.30.24309722
DO 10.1101/2024.06.30.24309722
A1 Phong, Nguyen Thanh
A1 Duc, Du Hong
A1 Hai, Ho Bich
A1 Nguyen Thanh, Nguyen
A1 Khoa, Le Dinh Van
A1 Khanh, Le Thuy Thuy
A1 Tran, Luu Hoai Bao
A1 Linh, Nguyen Thi My
A1 Van, Cao Thi Cam
A1 Thao, Dang Phuong
A1 Trinh, Nguyen Thi Diem
A1 Kieu, Pham Tieu
A1 Truong, Nguyen Thanh
A1 Hoang, Vo Tan
A1 Ngoc, Nguyen Thanh
A1 Vien, Tran Thi Dong
A1 Ly, Vo Trieu
A1 Khoa, Tran Dang
A1 Beane, Abigail
A1 Anibal, James
A1 ,
A1 Thwaites, Guy E
A1 Geskus, Ronald B
A1 Clifton, David
A1 Dung, Nguyen Thi Phuong
A1 Kestelyn, Evelyne
A1 Glover, Guy
A1 Tan, Le Van
A1 Yen, Lam Minh
A1 Tung, Nguyen Le Nhu
A1 Dung, Nguyen Thanh
A1 Thwaites, C Louise
YR 2024
UL http://medrxiv.org/content/early/2024/07/01/2024.06.30.24309722.abstract
AB Objectives We evaluated the efficacy and acceptability of awake-prone positioning (APP) in a randomised controlled trial, using a dedicated APP implementation team and wearable continuous-monitoring devices to monitor position and oximetry.Methods The trial was performed at a tertiary level hospital in Ho Chi Minh City, Vietnam, recruiting adults (≥18 years) hospitalised with moderate or severe COVID-19 and receiving supplemental oxygen therapy via nasal/facemask systems or high-flow nasal canulae. Participants were randomized (1:1) to standard care or APP. The primary outcome was escalation of respiratory support within 28 days of randomisation.Results Ninety-three patients were enrolled between March 2022 and March 2023; 80 (86%) had received ≥2 doses of SARS-CoV2 vaccine. Significantly greater mean daily APP times were achieved in those allocated to APP, although most did not achieve the target 8 hours/day. We did not detect significant differences in the primary outcome (RR 0.85, 95% CI 0.40-1.78, p=0.67) or secondary outcomes, including intubation rate and 28-day mortality. Particpants reported prone positioning was comfortable, although almost all preferred supine positioning. No adverse events associated with the intervention were reported.Conclusions APP was not associated with benefit, but was safe. Continuous monitoring with wearable devices was feasible and acceptable to patients.Clinical Trials Registration NCT05083130Funding Wellcome Trust Grant 089276/B/09/7, 217650/Z/19/Z and FDCO/Wellcome Trust 225437/Z/22/ZCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialNCT05083130Clinical Protocols https://wellcomeopenresearch.org/articles/8-235 Funding StatementThe study was funded by the Wellcome TrustAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of the Hospital for Tropical Diseases, Ho Chi Minh City and Oxford Tropical Research Ethics Committee approved this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors